Deletion of protein kinase D1 in myeloid lineage cells suppresses development of IFNγ +IL-17A +CD4 T cells and ameliorates hypersensitivity pneumonitis

Ae-Kyung Yi,John D Snyder,Tae Won Yoon,Elizabeth A Fitzpatrick
DOI: https://doi.org/10.4049/jimmunol.210.supp.67.19
2023-05-01
The Journal of Immunology
Abstract:Abstract Hypersensitivity pneumonitis (HP) is an extrinsic allergic alveolitis characterized by inflammation of the interstitium, bronchioles, and alveoli of the lung that leads to granuloma formation and ultimately irreversible fibrosis. Previous studies found that exposure to HP inciting antigen S. rectivirgula(SR) leads to the activation of protein kinase D1 (PKD1) in the mouse lung in vivoand that PKD1 contributes to the acute pulmonary inflammation, IL-17A expression in the lungs, and development of HP caused by repeated exposure to SR. In the present study, we investigated whether PKD1 in myeloid cells affects the pathogenic course of the SR-induced HP. Compared to control PKD1-sufficient mice, mice with deficiency of PKD1 in myeloid cells (PKD1mKO) showed significantly suppressed expression of IL-6, TNFα, IFNγ, CCL2, CCL3, CCL4, CXCL1, CXCL2, and CXCL10 and neutrophilic alveolitis after single intranasal exposure to SR. Substantially reduced levels of alveolitis and granuloma formation were observed in the PKD1mKO mice repeatedly exposed to SR. Surface expression of MHC-II and CD86 on myeloid cells, and expression of IFNγ, IL-17A, CCL20, CXCL9, and CXCL10 in lungs were significantly reduced in the PKD1mKO mice repeatedly exposed to SR. In addition, surface expression of CD69, CXCR3, and CCR6 on CD4 T cells and frequency of IFNγ +IL-17A +CD4 T cells in the lungs were significantly reduced in PKD1mKO mice repeatedly exposed to SR. Our results demonstrate PKD1 in myeloid lineage cells plays an essential role in the initial proinflammatory responses and neutrophil influx in the lung after exposed to SR and contributes to the development of IFNγ +IL-17A +CD4 T cells and HP caused by repeated exposure to SR. Supported by grants from NIH (R01 AR064723, R01 AR069010) and UTHSC.
immunology
What problem does this paper attempt to address?